How to use dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab and extended therapy with neratinib for patients with HER2+ EBC
Stephen Ansell, MD, PhD presents data on treating patients with newly diagnosed mantel cell lymphoma and how to use ibrutinib and acalabrutinib after progression.
Downloadable slides with expert advice for managing patients with non-small-cell lung cancer (NSCLC) using the latest treatment strategies.
Stephen Ansell, MD, PhD, reviews practice-changing data and expert recommendations for treating patients with mantle cell lymphoma (MCL).
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.